PXF - ETF AI Analysis
Top Page
Invesco FTSE RAFI Developed Markets ex-U.S. ETF (PXF)
PXF, the Invesco FTSE RAFI Developed Markets ex-U.S. ETF, has a solid overall rating driven by strong, diversified holdings like HSBC, Toyota, and Novartis, which show healthy financials, supportive technical trends, and generally positive earnings call sentiment. Large positions in energy names such as Shell and BP, along with cyclical exposure through BHP, add to return potential but introduce risks from sector-specific challenges, short-term technical weakness, and leverage or growth concerns that modestly hold back the fund’s rating.
PXF vs. SPDR S&P 500 ETF (SPY)
- AUM
- 3.05B
- Region
- Developed Markets
- Expense Ratio
- 0.43%
- Beta
- 0.69
- Issuer
- Invesco
- Inception Date
- Jun 25, 2007
- Dividend Yield
- 3.30%
- Asset Class
- Equity
- Index Tracked
- RAFI Fundamental Select Developed ex U.S. 1000 Index - Benchmark TR Net
PXF Summary
PXF is an ETF that follows the RAFI Fundamental Select Developed ex U.S. 1000 Index, giving you broad exposure to stocks from developed countries outside the United States, such as Japan, the UK, and Europe. Instead of focusing on the biggest companies by size, it picks and weights companies based on business strength measures like sales and dividends. It holds well-known names like Samsung Electronics, Toyota Motor, Shell, BP, Nestlé, and Novartis. Someone might invest in PXF for international diversification and long-term growth potential. A key risk is that its value can go up and down with global stock markets.
How much will it cost me?
PXF has an expense ratio of 0.43%, which means you’ll pay about $4.30 per year for every $1,000 invested. This cost is a bit higher than the average index ETF because PXF uses a more complex, fundamentally based strategy rather than simple passive market-cap weighting.
What would affect this ETF?
PXF could benefit if developed markets outside the U.S. grow steadily, especially in sectors like financials, industrials, and energy, and if global demand supports major holdings such as Samsung, Shell, Toyota, and Nestlé. On the downside, slower economic growth abroad, falling commodity prices, currency swings versus the U.S. dollar, or new regulations affecting banks, energy companies, or large exporters could weigh on the fund’s future performance.
PXF Top 10 Holdings
PXF leans heavily on a mix of European energy giants and global healthcare names to drive returns. Shell, TotalEnergies, and BP have been rising, giving the fund a solid tailwind from the energy patch, while Novartis and Roche add steady, defensive strength from Switzerland’s pharma hub. Samsung sits quietly at the top, more steady than surging, and Toyota has been mixed, losing a bit of steam year-to-date. With broad sector exposure but a noticeable tilt toward energy and healthcare, and holdings spread across Europe and Asia, this ETF is a diversified ex‑U.S. play with a few clear engines of performance.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 KR:005930 | Samsung Electronics | 2.93% | $88.81M | KRW 1389.90T | 100.30% | ―― |
 GB:SHEL | Shell (UK) | 2.42% | $73.43M | GBP 215.38B | 32.15% | 73Outperform |
 FR:TTE | TotalEnergies SE | 1.53% | $46.45M | EUR 182.08B | 50.34% | 78Outperform |
 RHHVF | Roche Holding AG | ― | ― | ― | ― | 73Outperform |
 GB:HSBA | HSBC Holdings | 1.14% | $34.70M | GBP 225.86B | 20.41% | 80Outperform |
 JP:7203 | Toyota Motor | 1.03% | $31.27M | JPY 35.86T | 16.22% | 80Outperform |
 GB:BP | BP p.l.c. | 0.94% | $28.45M | GBP 88.33B | 23.00% | 71Outperform |
 AU:BHP | BHP Group Ltd | 0.89% | $27.06M | AUD 282.44B | 39.35% | 68Neutral |
 CH:NESN | Nestlé SA | 0.80% | $24.15M | CHF 220.95B | 10.36% | 71Outperform |
 CH:NOVN | Novartis AG | 0.80% | $24.33M | CHF 245.77B | 32.03% | 80Outperform |
PXF Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For PXF, the sentiment is Negative. The current price of 75.52 is below the 20-day moving average (MA) of 76.22, below the 50-day MA of 77.21, and above the 200-day MA of 74.37, indicating a neutral trend. The MACD of -0.14 indicates Negative momentum. The RSI at 43.54 is Neutral, neither overbought nor oversold. The STOCH value of 46.19 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for PXF.
PXF Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| PXF | $75.52 | $81.00(7.26% Upside) | $3.05B | 0.43% | 62Neutral |
 LVHI | $43.09 | $47.73(10.77% Upside) | $6.47B | 0.40% | 67Neutral |
 GSIE | $45.98 | $57.56(25.18% Upside) | $6.02B | 0.25% | 65Neutral |
 IMTM | $48.75 | $67.12(37.68% Upside) | $4.19B | 0.30% | 69Neutral |
 IDMO | $55.54 | $74.64(34.38% Upside) | $4.19B | 0.25% | 71Outperform |
 INTF | $40.84 | $50.89(24.60% Upside) | $3.77B | 0.16% | 64Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| PXF | Invesco FTSE RAFI Developed Markets ex-U.S. ETF | 75.52 | 15.27 | 25.35% | |
| LVHI | Legg Mason International Low Volatility High Dividend ETF | 43.09 | 8.87 | 25.91% | |
| GSIE | Goldman Sachs ActiveBeta International Equity ETF | 45.98 | 5.81 | 14.46% | |
| IMTM | iShares MSCI Intl Momentum Factor ETF | 48.75 | 3.10 | 6.79% | |
| IDMO | Invesco S&P International Developed Momentum ETF | 55.54 | 3.79 | 7.33% | |
| INTF | iShares MSCI Intl Multifactor ETF | 40.84 | 5.63 | 15.98% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.